These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33502599)

  • 1. Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications?
    Schellekens P; Roosens W; Meyts I; Vennekens R; Bammens B; Mekahli D
    Pediatr Nephrol; 2021 Nov; 36(11):3505-3514. PubMed ID: 33502599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocytic leukopenia in two patients affected by polycystic kidney disease waiting for renal transplantation].
    Costa E; Giuliani A; Corradi V; Caprara C; Rigato M; Milan Manani S; Tantillo I; Ronco C; Gastaldon F; Zanella M
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
    Noël N; Rieu P
    Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.
    Saini AK; Saini R; Singh S
    Mol Med; 2020 Dec; 26(1):128. PubMed ID: 33308138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
    Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
    BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
    Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment.
    Helal I; Reed B; Schrier RW
    Am J Nephrol; 2012; 36(2):162-7. PubMed ID: 22846584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
    Xu Y; Li A; Wu G; Liang C
    Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population.
    Vikrant S; Parashar A
    Saudi J Kidney Dis Transpl; 2017; 28(1):115-124. PubMed ID: 28098112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis.
    Driscoll JA; Bhalla S; Liapis H; Ibricevic A; Brody SL
    Chest; 2008 May; 133(5):1181-8. PubMed ID: 18263686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary Tract and Liver Complications in Polycystic Kidney Disease.
    Judge PK; Harper CHS; Storey BC; Haynes R; Wilcock MJ; Staplin N; Goldacre R; Baigent C; Collier J; Goldacre M; Landray MJ; Winearls CG; Herrington WG
    J Am Soc Nephrol; 2017 Sep; 28(9):2738-2748. PubMed ID: 28465378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).
    Norman J
    Biochim Biophys Acta; 2011 Oct; 1812(10):1327-36. PubMed ID: 21745567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Kleczko EK; Marsh KH; Tyler LC; Furgeson SB; Bullock BL; Altmann CJ; Miyazaki M; Gitomer BY; Harris PC; Weiser-Evans MCM; Chonchol MB; Clambey ET; Nemenoff RA; Hopp K
    Kidney Int; 2018 Dec; 94(6):1127-1140. PubMed ID: 30249452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pancreatitis with polycystic kidney disease: A rare coincidence?
    Hrčková G; Hegyi E; Skalická K; Čierna I; Dallos T; Ilenčíková D
    Nefrologia (Engl Ed); 2020; 40(3):351-355. PubMed ID: 31862184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
    Kocyigit I; Ozturk F; Eroglu E; Karaca Z; Kaynar AS; Cetin M; Tokgoz B; Sipahioglu MH; Bayramov R; Sen A; Oymak O; Ecder T; Axelsson J
    Clin Exp Nephrol; 2019 Sep; 23(9):1130-1140. PubMed ID: 31134465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.